Artal Group S.A.

Holdings History for Y-mAbs Therapeutics, Inc. - Common Stock, $0.0001 par value per share (YMAB)

Symbol: YMAB
Investment type: Equity / Common Stock, $0.0001 par value per share

Shares, Excluding Options vs Price

Value, Excluding Options

Holdings date	Weight	Change	Value $	Shares	Change	Activity %	Price	All Holders
31 Mar 2023		-0.11%	$0	0	-400,000	-100%	$8.61	Q1 2023
31 Dec 2022	0.11%	0%	$1,952,000	400,000	0		$4.88	Q4 2022
30 Sep 2022	0.3%	0%	$5,768,000	400,000	0		$14.42	Q3 2022
30 Jun 2022	0.34%	0%	$6,052,000	400,000	0		$15.13	Q2 2022
31 Mar 2022	0.2%	0%	$4,752,000	400,000	0		$11.88	Q1 2022
31 Dec 2021	0.19%	0%	$6,484,000	400,000	0		$16.21	Q4 2021
30 Sep 2021	0.28%	0%	$11,416,000	400,000	0		$28.54	Q3 2021
30 Jun 2021	0.31%	0%	$13,520,000	400,000	0		$33.80	Q2 2021
31 Mar 2021	0.26%	+0.07%	$12,096,000	400,000	+114,972	+40%	$30.24	Q1 2021
31 Dec 2020	0.32%	0%	$14,112,000	285,028	0		$49.51	Q4 2020
30 Sep 2020	0.36%	-0.02%	$10,942,000	285,028	-15,002	-5%	$38.39	Q3 2020
30 Jun 2020	0.44%	-0.15%	$12,961,000	300,030	-99,970	-25%	$43.20	Q2 2020
31 Mar 2020	0.5%	0%	$10,440,000	400,000	0		$26.10	Q1 2020
31 Dec 2019	0.52%	0%	$12,500,000	400,000	0		$31.25	Q4 2019
30 Sep 2019	0.51%	0%	$10,424,000	400,000	0		$26.06	Q3 2019
30 Jun 2019	0.42%	+0.42%	$9,148,000	400,000	+400,000	NEW	$22.87	Q2 2019
31 Mar 2019		-0.05%	$0	0	-50,000	-100%	$8.61	Q1 2019
31 Dec 2018	0.05%	-0.1%	$1,017,000	50,000	-100,000	-67%	$20.34	Q4 2018
30 Sep 2018	0.14%	+0.14%	$3,984,000	150,000	+150,000	NEW	$26.56	Q3 2018

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.